Correlation Between Anheuser Busch and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Anheuser Busch and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anheuser Busch and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anheuser Busch Inbev and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Anheuser Busch and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anheuser Busch with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anheuser Busch and Regeneron Pharmaceuticals.
Diversification Opportunities for Anheuser Busch and Regeneron Pharmaceuticals
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Anheuser and Regeneron is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Anheuser Busch Inbev and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Anheuser Busch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anheuser Busch Inbev are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Anheuser Busch i.e., Anheuser Busch and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Anheuser Busch and Regeneron Pharmaceuticals
Considering the 90-day investment horizon Anheuser Busch Inbev is expected to generate 0.85 times more return on investment than Regeneron Pharmaceuticals. However, Anheuser Busch Inbev is 1.18 times less risky than Regeneron Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 6,265 in Anheuser Busch Inbev on September 1, 2024 and sell it today you would lose (885.00) from holding Anheuser Busch Inbev or give up 14.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anheuser Busch Inbev vs. Regeneron Pharmaceuticals
Performance |
| Timeline |
| Anheuser Busch Inbev |
| Regeneron Pharmaceuticals |
Anheuser Busch and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anheuser Busch and Regeneron Pharmaceuticals
The main advantage of trading using opposite Anheuser Busch and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anheuser Busch position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.| Anheuser Busch vs. Boston Beer | Anheuser Busch vs. Molson Coors Beverage | Anheuser Busch vs. Heineken NV | Anheuser Busch vs. Ambev SA ADR |
| Regeneron Pharmaceuticals vs. Tff Pharmaceuticals | Regeneron Pharmaceuticals vs. Eliem Therapeutics | Regeneron Pharmaceuticals vs. Inhibrx | Regeneron Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |